Z. Diaz et al., CENTRALLY INFUSED GALANIN-(1-15) BUT NOT GALANIN-(1-29) REDUCES THE BARORECEPTOR REFLEX SENSITIVITY IN THE RAT, Brain research, 741(1-2), 1996, pp. 32-37
It has been demonstrated previously that central administration of the
N-terminal galanin fragment (1-15) elicits hypertension and tachycard
ia and antagonizes the hypotensive effect of the parent molecule galan
in-(1-29). In order to further clarify the role of galanin in central
cardiovascular control, the possible modulation of the baroreceptor re
flex by both galanin molecules has been studied. Different groups of r
ats were injected in the lateral ventricle with subthreshold doses of
galanin-(1-15) (0.1 nmol/rat, or 0.3 nmol/rat), with subthreshold dose
s of galanin-(1-29) (0.1 nmol/rat, and 0.3 nmol/rat) or with an effect
ive dose of galanin-(1-29) (3.0 nmol/rat). The baroreceptor reflex was
elicited by intravenous injections of different doses of L-phenylephr
ine before and after the intraventricular administration of galanin pe
ptides. The changes of the bradycardic responses after galanin peptide
injections as well as the modifications of the baroreceptor reflex se
nsitivity were evaluated. Intraventricular injections of galanin-(1-15
) significantly inhibited the reflex bradycardia elicited by intraveno
us L-phenylephrine and thus decreased the baroreceptor sensitivity. Ho
wever, neither subthreshold doses of galanin-(1-29) nor its effective
dose were able to modulate these cardiovascular responses. From these
data it may be suggested that the galanin fragment(1-15) plays a more
important role in central cardiovascular regulation than galanin-(1-29
), possibly acting on a specific receptor subtype which exclusively re
cognizes N-terminal fragments of galanin, and exists on cardiovascular
areas of the central nervous system.